In some ARMS guidelines, 6, 7 psychological treatments, including cognitive behavioral therapy (CBT), are recommended as a first-line treatment, whereas antipsychotics should not be prescribed except in cases of rapid worsening of psychotic symptoms that are unresponsive to psychological treatment or increasing risk of self-harm or harm to others. Antipsychotics are not recommended due to the ethical issue of 'false positives.' A meta-analysis indicated that although the average transition rate to psychosis in ARMS was much higher than in the general population, approximately two-thirds of patients did not develop psychosis over mediumterm follow up. 8 Antipsychotics may be unnecessary for patients who would not develop psychosis. There are also concerns about adverse effects, including extrapyramidal symptoms and metabolic disorders. While CBT is effective 9, 10 and physically safer in patients with ARMS, it is not always accessible and remains an uncommon therapy in Japan.
Although there, thus, appear to be several issues in the diagnosis and treatment of ARMS, psychiatrists' recognition of ARMS in practice is unknown. We therefore used fictional case vignettes to examine how Japanese psychiatrists diagnose and treat patients with ARMS. A previous study 11 using nearly identical methods found that ARMS vignettes were frequently misdiagnosed as describing schizophrenia. We sought to determine if misdiagnosis rates were still high. In the 8 years since the previous study, the International Conference on Early Psychosis has been held in Japan, and the situation of early intervention for psychosis is changing. It is therefore important to examine Japanese psychiatrists' recognition of ARMS.
METHODS Participants
The participants were 1399 Japanese psychiatrists who worked in Tokyo and whose information was posted online. We used an anonymous selfadministered questionnaire to collect basic demographic data, including sex, duration of clinical psychiatric experience, facility type, weekly number of patients managed, and weekly number of young patients managed. We mailed study documents to all eligible participants in November 2015 with a requested return date in December. The Toho University School of Medicine's Ethical Research Committee approved this study (27033), and participants' consent was implied by the return of the questionnaires. The research was performed in accordance with the Declaration of Helsinki.
Measures
We prepared clinical vignettes (Appendix S1) of four fictional patients for this survey. Two clinical vignettes describing patients with ARMS, one with attenuated positive symptom syndrome (APSS) and the other with brief intermittent psychotic syndrome (BIPS), were written based on the Criteria of Psychosis-Risk Syndromes in the Structured Interview for PsychosisRisk Syndromes/Scale of Psychosis-Risk Symptoms. 12 Two clinical vignettes, one describing full-blown schizophrenia and the other describing depression, were written based on the DSM-5 3 for comparison with ARMS. For each vignette, respondents were asked what diagnosis they would give and what treatment they would recommend. If respondents chose pharmacotherapy, subsequent questions asked which medications they would prescribe. The respondents answered the questions by selecting response options, except for the diagnosis question, which they answered with free writing.
Statistical analysis
This survey was analyzed with a cross-sectional design. We compared the psychiatrists who correctly diagnosed the ARMS vignettes to those who diagnosed them as non-ARMS based on collected demographic data. We used the χ 2 -test to compare them in regards to their sex and the Mann-Whitney U-test to compare them in terms of years of clinical psychiatric experience, number of patients managed, and number of young patients managed. Furthermore, we divided the psychiatrists into four groups based on years of clinical experience: (i) fewer than 10 years; (ii) 10-19 years; (iii) 20-29 years; and (iv) 30 or more years. We then used the χ 2 -test and residual analysis to compare psychiatrists who correctly diagnosed patients in the ARMS vignettes to those who diagnosed them as non-ARMS based on these four groups. All P-values were two-tailed, significance was defined as P < 0.05, and adjusted residuals ≥1.96 or ≤−1.96 were considered significant. Means are reported with SD. Statistical analyses were conducted with SPSS 23.0 (IBM, Armonk, NY).
RESULTS

Respondent characteristics
The response rate was 19.3% (n = 260) after subtracting those without forwarding addresses and those who were retired (n = 55). The respondents' demographic characteristics are shown in Table 1 15 .0 AE 9.0 years for those who worked in university hospitals, and 17.6 AE 8.6 years for those who worked in other settings. The duration of the clinical psychiatric experience significantly correlated (r = 0.22, P < 0.01) with the number of weekly patients.
Diagnoses
For the vignette describing ARMS with APSS, the correct diagnosis rate was 14.6%, and for the vignette describing ARMS with BIPS, it was 13.1%. Patients in the two vignettes were misdiagnosed as describing schizophrenia by 59.6% and 43.1% of the respondents, respectively. The ARMS vignettes had lower diagnostic concordance rates than did the vignettes describing full-blown schizophrenia or depression (Table 2 ).
Treatments
For each vignette, most respondents recommended pharmacotherapy. However, the percentages of respondents recommending pharmacotherapy for the vignettes describing ARMS with APSS (80.0%) or BIPS (56.9%) were lower than those for the vignettes describing full-blown schizophrenia (97.7%) or depression (85.0%). The percentages recommending CBT for the vignettes describing ARMS with APSS or BIPS were 1.9% and 3.5%, respectively. Similarly, the percentages recommending psychoeducation or family psychoeducation were low. The percentages recommending observation for the vignettes describing ARMS with APSS or BIPS were higher than those for the vignettes describing full-blown schizophrenia or depression (Table 2) .
Of those who correctly diagnosed the vignette describing ARMS with APSS, 55.2% recommended pharmacotherapy and 7.8% recommended CBT. Of those who correctly diagnosed the vignette describing ARMS with BIPS, 41.2% recommended pharmacotherapy and 11.7% recommended CBT (Table 3) . 
Medication types
For the vignettes describing schizophrenia or ARMS with APSS or BIPS, the most frequently recommended drugs were antipsychotics. For the vignette describing depression, antidepressants were recommended by 78.7% of respondents recommending pharmacotherapy (Table 2) . Of the respondents who correctly diagnosed the vignettes describing ARMS with APSS or BIPS, 76.2% and 92.8%, respectively, recommended antipsychotic pharmacotherapy (Table 3) .
Comparative demographic characteristics of respondents correctly diagnosing patients in the ARMS vignettes as ARMS or diagnosing them as non-ARMS
The respondents who correctly diagnosed patients in the ARMS vignettes had significantly fewer years of clinical psychiatric experience than those who diagnosed them as non-ARMS (12.5 years vs 22.7 years for the APSS vignette, P < 0.01; 14.3 years vs 22.2 years for the BIPS vignette, P < 0.01). Male respondents were significantly better represented among those who diagnosed the patients in the ARMS vignettes as non-ARMS than among those who correctly diagnosed them as ARMS. Most respondents who correctly diagnosed the patients in the ARMS vignettes worked in university hospitals, whereas most who diagnosed them as non-ARMS worked in outpatient clinics. In terms of the weekly numbers of patients managed and young patients managed, the respondents who correctly diagnosed patients in the ARMS vignettes had fewer than those who diagnosed them as non-ARMS. These numbers were significantly different for the APSS vignette but not for the BIPS vignette (Table 4) . Respondents with fewer than 10 years of experience were significantly more likely to correctly diagnose the patients in the ARMS vignette than those 
DISCUSSION
We set out to determine Japanese psychiatrists' correct diagnosis rates for ARMS and compare them to the rates for full-blown schizophrenia and depression. Diagnostic concordance rates were lower for the ARMS vignettes than for full-blown schizophrenia and depression vignettes, and patients in the ARMS vignettes were more likely to be diagnosed as describing schizophrenia than correctly diagnosed. This suggests that many psychiatrists could misdiagnose patients with ARMS as schizophrenic based on positive symptoms, even if the symptoms are 'attenuated' or 'briefly intermittent.' Our findings are partially consistent with those of a recent study reporting that psychiatrists reliably diagnosed ARMS in research settings but not clinical setteings.
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Two non-Japanese studies examined how clinicians diagnosed patients in clinical ARMS vignettes. 14, 15 One US study of clinical psychologists, psychiatrists, and general practitioners showed that 78.4% misdiagnosed the patients in the attenuated psychosis syndrome vignettes as describing schizophrenia or other psychotic disorders. 14 The other study examined psychiatrists and primary health-care physicians in Singapore and found that 44.8% of psychiatrists correctly diagnosed a patient in an ARMS vignette, while 43.7% misdiagnosed the patient as describing psychosis; whereas the figures for primary health-care physicians were 40.2% and 54.2%, respectively. 15 As with our results, these findings indicate that ARMS could be misdiagnosed as schizophrenia. As our case vignettes were different from those used in the previous studies, we cannot compare them directly.
A 2007 study in Japan conducted using almost the same method showed that the patient in the ARMS vignette was often misdiagnosed as describing schizophrenia (69% and 61% for the ARMS vignettes with APSS or BIPS, respectively) and less frequently correctly diagnosed (11% and 9% for the ARMS vignettes with APSS or BIPS, respectively).
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For the ARMS vignettes, we observed lower schizophrenia misdiagnosis rates and higher correct diagnosis rates than those in the 2007 study. Although it is difficult to directly compare our results to the previous study's results, a comparison suggests that the recognition of ARMS has been slightly more widely disseminated in Japan since 2007. We think that the DSM-5 including attenuated psychosis syndrome as a condition for further study and the 2014 9th International Conference on Early Psychosis (https://iepa.org.au/past-conferences/) being held in Japan might have improved Japanese psychiatrists' recognition of ARMS.
Psychiatrists should not diagnose schizophrenia based solely on positive symptoms, because many patients with ARMS may not develop psychosis. Furthermore, psychotic experiences have often been recognized among the general population 16 and among patients with other psychopathologies, such as depression or anxiety disorder. 17, 18 Although more patients with attenuated or brief intermittent psychotic symptoms have been visiting medical institutions before developing schizophrenia, non-specialist psychiatrists may be unfamiliar with these patients. 16 The European Psychiatric Association recommends that a trained specialist with sufficient practice in ARMS should make the diagnosis and that inexperienced clinicians should consult a trained specialist. For treating ARMS, most psychiatrists recommended pharmacotherapy, with antipsychotics being the most frequently recommended drug. This may reflect the misdiagnosis of ARMS vignettes as describing schizophrenia. However, pharmacotherapy generally and antipsychotics specifically were recommended less frequently for the ARMS vignettes than for the full-blown schizophrenia vignette. This could be caused by the difference in psychotic symptom intensity between ARMS and full-blown schizophrenia. Additionally, the psychiatrists who correctly diagnosed patients in the ARMS vignettes mostly recommended pharmacotherapy and antipsychotics, which suggests that the ARMS guidelines 6, 7 have not been widely disseminated in Japan. To disseminate these guidelines widely, it will be necessary not only to translate them into Japanese, but also to make an original version in Japan. Furthermore, if the original Japanese guideline were to become well known to school workers and parents of children and adolescents, psychiatrists would be compelled to observe the guideline and to maintain precise knowledge of ARMS. Additionally, Japanese psychiatrists would have the opportunity to evaluate the effectiveness of antipsychotics for ARMS. In other countries, cohort studies have reported that approximately 87% of patients with ARMS (n = 67) in South Korea 20 and approximately 23.7% of patients with ARMS (n = 372) in the USA 21 received antipsychotic medications. It thus appears that antipsychotic prescription rates vary internationally. In Japan and South Korea, the ARMS guidelines may not have been sufficiently disseminated, or psychiatrists may expect that antipsychotics can prevent the transition to full-blown psychosis in individuals with ARMS. Although the guidelines state that antipsychotic prescriptions should be avoided, the existence of reports suggesting efficacy without establishing risks demands further study into the risks and benefits of different antipsychotics for patients with ARMS. 22, 23 Alternatively, CBT is an effective and lowrisk treatment for ARMS, even in its early stage. However, it has not been sufficiently disseminated in Japan, so it could not be selected by Japanese psychiatrists in this survey. Similarly, the importance of psychoeducation and family psychoeducation might not have been sufficiently disseminated in Japan.
Our analysis showed that younger psychiatrists, especially those with fewer than 10 years of experience, were more likely to correctly diagnose patients in the ARMS vignettes. This could be because the ARMS diagnostic category was advocated recently, so younger psychiatrists are more familiar with it. Another possibility is that older psychiatrists made diagnoses relying on their clinical experience rather than diagnostic criteria, the details of which they cannot always keep up with. Differences in sex, facility type, weekly number of patients managed, and weekly number of young patients managed could be associated with duration of clinical experience.
This study has several limitations. First, we used hypothetical clinical vignettes describing short case histories. In real-world practice, psychiatrists make diagnoses not only from obtaining the case history, but also from observing patients' appearance, attitude, manner of speaking, and other manifestations. Therefore, psychiatrists may offer different diagnoses for actual patients. Furthermore, we did not ask about comorbidity, and because ARMS is still merely a concept for study, respondents might have intentionally given the only diagnosis recognized in the international diagnostic criteria. Second, although respondents were asked to select only one treatment option in this questionnaire, psychiatrists often treat patients with multiple therapies. The survey did not ask about the respondent's specialty, so we could not analyze the relationship between the specialty and the selected treatment. Third, because the survey had a low response rate and was conducted in only one region, the results may not be nationally representative of Japan. However, the questionnaire had to be simplified to increase the response rate, and this limited the information available for analysis. Further studies should be conducted in other Japanese regions.
Notwithstanding this study's limitations, in conclusion, our findings indicate that patients with ARMS may be more likely to receive inappropriate diagnoses and treatments than are patients with fullblown schizophrenia or depression. However, recognition of ARMS may be more widely disseminated among Japan's younger psychiatrists.
